DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Sydes MR, Spears MR, Mason MD. et al; STAMPEDE Investigators.
Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol.
Ann Oncol 2018;
29 (05) 1235-1248
We do not assume any responsibility for the contents of the web pages of other providers.